Insider Transactions in Q1 2023 at Acutus Medical, Inc. (AFIB)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Charlie Piscitello SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+32.94%
|
-
|
|
Mar 01
2023
|
Takeo Mukai CFO |
BUY
Grant, award, or other acquisition
|
Direct |
47,500
+36.14%
|
-
|
|
Mar 01
2023
|
David Roman President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+26.05%
|
-
|
|
Mar 01
2023
|
Kevin Mathews SVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+38.94%
|
-
|
|
Mar 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+29.91%
|
-
|
|
Feb 01
2023
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
3,540
-12.78%
|
$3,540
$1.87 P/Share
|
|
Feb 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,196
-3.95%
|
$10,196
$1.87 P/Share
|
|
Feb 01
2023
|
Takeo Mukai CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,855
-7.26%
|
$2,855
$1.87 P/Share
|
|
Feb 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,525
-10.24%
|
$6,525
$1.87 P/Share
|
|
Feb 01
2023
|
Charlie Piscitello SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,627
-13.08%
|
$6,627
$1.87 P/Share
|